Getein Biotech Inc
SSE:603387
Getein Biotech Inc
SSE:603387
Price:
8.21
CNY
0.49%
Market Closed
Market Cap:
¥4.2B
Cash Flow Statement
Cash Flow Statement
Getein Biotech Inc
Getein Biotech Inc
Currency: CNY
| Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||||||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
(99)
|
(82)
|
(89)
|
(88)
|
(97)
|
(103)
|
(106)
|
(108)
|
(120)
|
(121)
|
(123)
|
(136)
|
(129)
|
(116)
|
(90)
|
(98)
|
(115)
|
(114)
|
(149)
|
(148)
|
(130)
|
(156)
|
(148)
|
(123)
|
(142)
|
(127)
|
(119)
|
(148)
|
(124)
|
(120)
|
(112)
|
(91)
|
(81)
|
(92)
|
(94)
|
|
| Change in Working Capital |
(175)
|
(151)
|
(173)
|
(167)
|
(199)
|
(221)
|
(233)
|
(275)
|
(300)
|
(308)
|
(329)
|
(329)
|
(335)
|
(327)
|
(325)
|
(374)
|
(389)
|
(430)
|
(483)
|
(514)
|
(529)
|
(614)
|
(635)
|
(597)
|
(626)
|
(615)
|
(623)
|
(646)
|
(640)
|
(570)
|
(523)
|
(569)
|
(570)
|
(561)
|
(569)
|
|
| Cash from Operating Activities |
177
N/A
|
170
-4%
|
172
+1%
|
192
+12%
|
194
+1%
|
187
-4%
|
166
-11%
|
187
+13%
|
156
-17%
|
163
+5%
|
165
+1%
|
226
+37%
|
187
-17%
|
194
+4%
|
252
+29%
|
186
-26%
|
244
+32%
|
299
+22%
|
201
-33%
|
432
+115%
|
487
+13%
|
449
-8%
|
543
+21%
|
483
-11%
|
430
-11%
|
461
+7%
|
422
-9%
|
333
-21%
|
387
+16%
|
378
-2%
|
437
+15%
|
423
-3%
|
405
-4%
|
407
+1%
|
408
+0%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||||||||||||||
| Capital Expenditures |
(51)
|
(55)
|
(66)
|
(61)
|
(68)
|
(60)
|
(72)
|
(111)
|
(113)
|
(113)
|
(103)
|
(125)
|
(122)
|
(118)
|
(142)
|
(114)
|
(116)
|
(137)
|
(117)
|
(180)
|
(193)
|
(203)
|
(185)
|
(217)
|
(217)
|
(253)
|
(295)
|
(258)
|
(261)
|
(183)
|
(151)
|
(156)
|
(166)
|
(199)
|
(223)
|
|
| Other Items |
(27)
|
(0)
|
(420)
|
(458)
|
(532)
|
(530)
|
(192)
|
(235)
|
(142)
|
(96)
|
(2)
|
387
|
523
|
51
|
178
|
(125)
|
(288)
|
261
|
188
|
(75)
|
(66)
|
(206)
|
(287)
|
(543)
|
(424)
|
(618)
|
(730)
|
(99)
|
(300)
|
(98)
|
36
|
(192)
|
(225)
|
(219)
|
(200)
|
|
| Cash from Investing Activities |
(78)
N/A
|
(55)
+30%
|
(486)
-787%
|
(519)
-7%
|
(600)
-16%
|
(590)
+2%
|
(263)
+55%
|
(346)
-31%
|
(255)
+26%
|
(209)
+18%
|
(105)
+50%
|
262
N/A
|
402
+54%
|
(67)
N/A
|
37
N/A
|
(239)
N/A
|
(404)
-69%
|
123
N/A
|
71
-43%
|
(255)
N/A
|
(259)
-2%
|
(409)
-58%
|
(471)
-15%
|
(760)
-61%
|
(641)
+16%
|
(872)
-36%
|
(1 025)
-18%
|
(357)
+65%
|
(561)
-57%
|
(282)
+50%
|
(115)
+59%
|
(348)
-203%
|
(392)
-13%
|
(418)
-7%
|
(423)
-1%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||||||||||||||
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
40
|
46
|
12
|
95
|
265
|
242
|
257
|
270
|
73
|
78
|
101
|
119
|
134
|
275
|
281
|
91
|
34
|
21
|
101
|
73
|
77
|
(42)
|
(30)
|
(79)
|
(32)
|
53
|
(108)
|
|
| Cash Paid for Dividends |
(65)
|
(108)
|
(108)
|
(68)
|
0
|
(60)
|
(60)
|
(60)
|
(60)
|
(77)
|
(77)
|
(78)
|
(78)
|
(104)
|
(106)
|
(116)
|
(119)
|
(112)
|
(112)
|
(104)
|
(105)
|
(136)
|
(143)
|
(141)
|
(142)
|
(173)
|
(218)
|
(219)
|
(224)
|
(116)
|
(112)
|
(111)
|
(105)
|
(105)
|
(103)
|
|
| Other |
0
|
2
|
676
|
671
|
697
|
700
|
42
|
58
|
34
|
32
|
19
|
9
|
8
|
15
|
36
|
46
|
51
|
42
|
22
|
(44)
|
(20)
|
(45)
|
(46)
|
4
|
(16)
|
2
|
(3)
|
0
|
(4)
|
(5)
|
(19)
|
(24)
|
(24)
|
(17)
|
(3)
|
|
| Cash from Financing Activities |
(65)
N/A
|
(106)
-63%
|
569
N/A
|
603
+6%
|
634
+5%
|
640
+1%
|
(18)
N/A
|
(2)
+92%
|
14
N/A
|
1
-96%
|
(47)
N/A
|
26
N/A
|
194
+648%
|
152
-21%
|
186
+22%
|
200
+7%
|
5
-98%
|
9
+80%
|
12
+34%
|
(29)
N/A
|
8
N/A
|
94
+1 009%
|
92
-2%
|
(46)
N/A
|
(124)
-170%
|
(151)
-22%
|
(120)
+20%
|
(146)
-21%
|
(152)
-4%
|
(164)
-8%
|
(161)
+2%
|
(214)
-33%
|
(161)
+25%
|
(69)
+57%
|
(215)
-211%
|
|
| Change in Cash | ||||||||||||||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
(1)
|
(1)
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
(6)
|
(6)
|
(5)
|
(9)
|
(3)
|
(1)
|
(5)
|
17
|
31
|
19
|
20
|
14
|
(2)
|
12
|
14
|
3
|
(1)
|
6
|
5
|
4
|
6
|
|
| Net Change in Cash |
35
N/A
|
9
-73%
|
254
+2 635%
|
275
+8%
|
226
-18%
|
237
+5%
|
(114)
N/A
|
(159)
-39%
|
(84)
+47%
|
(44)
+47%
|
14
N/A
|
514
+3 496%
|
785
+53%
|
281
-64%
|
469
+67%
|
141
-70%
|
(160)
N/A
|
422
N/A
|
281
-33%
|
148
-47%
|
232
+57%
|
151
-35%
|
194
+28%
|
(304)
N/A
|
(316)
-4%
|
(547)
-73%
|
(725)
-33%
|
(158)
+78%
|
(312)
-98%
|
(64)
+79%
|
160
N/A
|
(133)
N/A
|
(143)
-7%
|
(76)
+47%
|
(223)
-193%
|
|
| Free Cash Flow | ||||||||||||||||||||||||||||||||||||
| Free Cash Flow |
126
N/A
|
115
-9%
|
106
-8%
|
131
+24%
|
125
-4%
|
127
+1%
|
94
-26%
|
76
-19%
|
43
-44%
|
50
+18%
|
62
+24%
|
101
+62%
|
66
-35%
|
76
+16%
|
110
+44%
|
72
-34%
|
128
+78%
|
161
+26%
|
84
-48%
|
253
+201%
|
294
+16%
|
247
-16%
|
358
+45%
|
266
-26%
|
213
-20%
|
208
-2%
|
127
-39%
|
75
-41%
|
126
+67%
|
195
+55%
|
285
+46%
|
267
-7%
|
239
-11%
|
208
-13%
|
186
-11%
|
|
Switch to:
Switch to:
See Also
Discover More
